Prebiotic effects of plant-derived (poly)phenols on host metabolism: Is there a role for short-chain fatty acids?

References

• Aoki, R., K. Kamikado, W. Suda, H. Takii, Y. Mikami, N. Suganuma, M. Hattori, and Y. Koga. 2017. A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation. Scientific Reports 7:43522. doi: 10.1038/srep43522.
   PubMed Web of Science ®Google Scholar
• Armougom, F., M. Henry, B. Vialettes, D. Raccah, and D. Raoult. 2009. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS One 4 (9):e7125. doi: 10.1371/journal.pone.0007125.
   PubMed Web of Science ®Google Scholar
• Baboota, R. K., P. Khare, P. Mangal, D. P. Singh, K. K. Bhutani, K. K. Kondepudi, J. Kaur, and M. Bishnoi. 2018. Dihydrocapsiate supplementation prevented high-fat diet-induced adiposity, hepatic steatosis, glucose intolerance, and gut morphological alterations in mice. Nutrition Research 51:40–56. doi: 10.1016/j.nutres.2017.11.006.
   PubMed Web of Science ®Google Scholar
• Baothman, O. A., M. A. Zamzami, I. Taher, J. Abubaker, and M. Abu-Farha. 2016. The role of gut microbiota in the development of obesity and diabetes. Lipids in Health and Disease 15:108. doi: 10.1186/s12944-016-0278-4.
   PubMed Web of Science ®Google Scholar
• Boets, E., S. V. Gomand, L. Deroover, T. Preston, K. Vermeulen, V. De Preter, H. M. Hamer, G. Van den Mooter, L. De Vuyst, C. M. Courtin, et al. 2017. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: A stable isotope study. The Journal of Physiology 595 (2):541–55. doi: 10.1113/JP272613.
   PubMed Web of Science ®Google Scholar
• Brahe, L. K., A. Astrup, and L. H. Larsen. 2016. Can we prevent obesity-related metabolic diseases by dietary modulation of the gut microbiota? Advances in Nutrition 7 (1):90–101. doi: 10.3945/an.115.010587.
   PubMed Web of Science ®Google Scholar
• Brooks, L., A. Viardot, A. Tsakmaki, E. Stolarczyk, J. K. Howard, P. D. Cani, A. Everard, M. L. Sleeth, A. Psichas, J. Anastasovskaj, et al. 2017. Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety. Molecular Metabolism 6 (1):48–60. doi: 10.1016/j.molmet.2016.10.011.
   PubMed Web of Science ®Google Scholar
• Brown, A. J., S. M. Goldsworthy, A. A. Barnes, M. M. Eilert, L. Tcheang, D. Daniels, A. I. Muir, M. J. Wigglesworth, I. Kinghorn, N. J. Fraser, et al. 2003. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. The Journal of Biological Chemistry 278 (13):11312–9. doi: 10.1074/jbc.M211609200.
   PubMed Web of Science ®Google Scholar
• Cani, P. D. 2018. Human gut microbiome: Hopes, threats and promises. Gut 67 (9):1716–25. doi: 10.1136/gutjnl-2018-316723.
   PubMed Web of Science ®Google Scholar
• Cani, P. D. 2019. Microbiota and metabolites in metabolic diseases. Nature Reviews. Endocrinology 15 (2):69–70. doi: 10.1038/s41574-018-0143-9.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (7):1761–72. doi: 10.2337/db06-1491.
   PubMed Web of Science ®Google Scholar
• Cardona, F., C. Andres-Lacueva, S. Tulipani, F. J. Tinahones, and M. I. Queipo-Ortuno. 2013. Benefits of polyphenols on gut microbiota and implications in human health. The Journal of Nutritional Biochemistry 24 (8):1415–22. doi: 10.1016/j.jnutbio.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Clifford, M. N. 2004. Diet-derived phenols in plasma and tissues and their implications for health. Planta Medica 70 (12):1103–14. doi: 10.1055/s-2004-835835.
   PubMed Web of Science ®Google Scholar
• De Vadder, F., P. Kovatcheva-Datchary, D. Goncalves, J. Vinera, C. Zitoun, A. Duchampt, F. Backhed, and G. Mithieux. 2014. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156 (1-2):84–96. doi: 10.1016/j.cell.2013.12.016.
   PubMed Web of Science ®Google Scholar
• den Besten, G., K. van Eunen, A. K. Groen, K. Venema, D. J. Reijngoud, and B. M. Bakker. 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research 54 (9):2325–40. doi: 10.1194/jlr.R036012.
   PubMed Web of Science ®Google Scholar
• Ding, Y., Z. Song, H. Li, L. Chang, T. Pan, X. Gu, X. He, and Z. Fan. 2019. Honokiol ameliorates high-fat-diet-induced obesity of different sexes of mice by modulating the composition of the gut microbiota. Frontiers in Immunology 10:2800. doi: 10.3389/fimmu.2019.02800.
   PubMed Web of Science ®Google Scholar
• Dominguez-Bello, M. G., E. K. Costello, M. Contreras, M. Magris, G. Hidalgo, N. Fierer, and R. Knight. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proceedings of the National Academy of Sciences 107 (26):11971–5. doi: 10.1073/pnas.1002601107.
   PubMed Web of Science ®Google Scholar
• Duenas, M., I. Munoz-Gonzalez, C. Cueva, A. Jimenez-Giron, F. Sanchez-Patan, C. Santos-Buelga, M. V. Moreno-Arribas, and B. Bartolome. 2015. A survey of modulation of gut microbiota by dietary polyphenols. BioMed Research International 2015:850902. doi: 10.1155/2015/850902.
   PubMed Web of Science ®Google Scholar
• Eckburg, P. B., E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill, K. E. Nelson, and D. A. Relman. 2005. Diversity of the human intestinal microbial flora. Science 308 (5728):1635–8. doi: 10.1126/science.1110591.
   PubMed Web of Science ®Google Scholar
• Everard, A., C. Belzer, L. Geurts, J. P. Ouwerkerk, C. Druart, L. B. Bindels, Y. Guiot, M. Derrien, G. G. Muccioli, N. M. Delzenne, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 110 (22):9066–71. doi: 10.1073/pnas.1219451110.
   PubMed Web of Science ®Google Scholar
• Freeland, K. R, and T. M. Wolever. 2010. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. British Journal of Nutrition 103 (3):460–6. doi: 10.1017/S0007114509991863.
   PubMed Web of Science ®Google Scholar
• Frost, G., M. L. Sleeth, M. Sahuri-Arisoylu, B. Lizarbe, S. Cerdan, L. Brody, J. Anastasovska, S. Ghourab, M. Hankir, S. Zhang, et al. 2014. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nature Communications 5:3611. doi: 10.1038/ncomms4611.
   PubMed Web of Science ®Google Scholar
• Furet, J.-P., L.-C. Kong, J. Tap, C. Poitou, A. Basdevant, J.-L. Bouillot, D. Mariat, G. Corthier, J. Doré, C. Henegar, et al. 2010. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes 59 (12):3049–57. doi: 10.2337/db10-0253.
   PubMed Web of Science ®Google Scholar
• Gao, X., S.-H. Lin, F. Ren, J.-T. Li, J.-J. Chen, C.-B. Yao, H.-B. Yang, S.-X. Jiang, G.-Q. Yan, D. Wang, et al. 2016. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nature Communications 7:11960. doi: 10.1038/ncomms11960.
   PubMed Web of Science ®Google Scholar
• Gao, Z., J. Yin, J. Zhang, R. E. Ward, R. J. Martin, M. Lefevre, W. T. Cefalu, and J. Ye. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58 (7):1509–17. doi: 10.2337/db08-1637.
   PubMed Web of Science ®Google Scholar
• Gibson, G. R., R. Hutkins, M. E. Sanders, S. L. Prescott, R. A. Reimer, S. J. Salminen, K. Scott, C. Stanton, K. S. Swanson, P. D. Cani, et al. 2017. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology 14 (8):491–502. doi: 10.1038/nrgastro.2017.75.
   PubMed Web of Science ®Google Scholar
• Gill, P. A., M. C. van Zelm, J. G. Muir, and P. R. Gibson. 2018. Review article: Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Alimentary Pharmacology & Therapeutics 48 (1):15–34. doi: 10.1111/apt.14689.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Diaz, I., N. Salazar, J. Perez-Jimenez, C. G. de Los Reyes-Gavilan, M. Gueimonde, and S. Gonzalez. 2021. New players in the relationship between diet and microbiota: The role of macromolecular antioxidant polyphenols. European Journal of Nutrition 60 (3):1403–13. doi: 10.1007/s00394-020-02339-5.
   PubMed Web of Science ®Google Scholar
• Henning, S. M., J. Yang, M. Hsu, R. P. Lee, E. M. Grojean, A. Ly, C. H. Tseng, D. Heber, and Z. Li. 2018. Decaffeinated green and black tea polyphenols decrease weight gain and alter microbiome populations and function in diet-induced obese mice. European Journal of Nutrition 57 (8):2759–69. doi: 10.1007/s00394-017-1542-8.
   PubMed Web of Science ®Google Scholar
• Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486 (7402):207–14. doi: 10.1038/nature11234.
   PubMed Web of Science ®Google Scholar
• Jocken, J. W. E., M. A. Gonzalez Hernandez, N. T. H. Hoebers, C. M. van der Beek, Y. P. G. Essers, E. E. Blaak, and E. E. Canfora. 2017. Short-chain fatty acids differentially affect intracellular lipolysis in a human white adipocyte model. Frontiers in Endocrinology 8:372. doi: 10.3389/fendo.2017.00372.
   PubMed Web of Science ®Google Scholar
• Kang, C., B. Wang, K. Kaliannan, X. Wang, H. Lang, S. Hui, L. Huang, Y. Zhang, M. Zhou, M. Chen, et al. 2017. Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet. mBio 8 (3):e00470–17. doi: 10.1128/mBio.00470-17.
   PubMed Web of Science ®Google Scholar
• Kennedy, K. M., M. J. Gerlach, T. Adam, M. M. Heimesaat, L. Rossi, M. G. Surette, D. M. Sloboda, and T. Braun. 2021. Fetal meconium does not have a detectable microbiota before birth. Nature Microbiology 6 (7):865–73. doi: 10.1038/s41564-021-00904-0.
   PubMed Web of Science ®Google Scholar
• Kibbie, J. J., S. M. Dillon, T. A. Thompson, C. M. Purba, M. D. McCarter, and C. C. Wilson. 2021. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling. Immunobiology 226 (5):152126. doi: 10.1016/j.imbio.2021.152126.
   PubMed Web of Science ®Google Scholar
• Koh, A., F. De Vadder, P. Kovatcheva-Datchary, and F. Backhed. 2016. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165 (6):1332–45. doi: 10.1016/j.cell.2016.05.041.
   PubMed Web of Science ®Google Scholar
• Larraufie, P., C. Martin-Gallausiaux, N. Lapaque, J. Dore, F. M. Gribble, F. Reimann, and H. M. Blottiere. 2018. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Scientific Reports 8 (1):74. doi: 10.1038/s41598-017-18259-0.
   PubMedGoogle Scholar
• Ley, R. E., F. Backhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon. 2005. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 102 (31):11070–5. doi: 10.1073/pnas.0504978102.
   PubMed Web of Science ®Google Scholar
• Ley, R. E., C. A. Lozupone, M. Hamady, R. Knight, and J. I. Gordon. 2008. Worlds within worlds: Evolution of the vertebrate gut microbiota. Nature Reviews. Microbiology 6 (10):776–88. doi: 10.1038/nrmicro1978.
   PubMed Web of Science ®Google Scholar
• Ley, R. E., P. J. Turnbaugh, S. Klein, and J. I. Gordon. 2006. Microbial ecology: Human gut microbes associated with obesity. Nature 444 (7122):1022–3. doi: 10.1038/4441022a.
   PubMed Web of Science ®Google Scholar
• Li, X., K. Watanabe, and I. Kimura. 2017. Gut microbiota dysbiosis drives and implies novel therapeutic strategies for diabetes mellitus and related metabolic diseases. Frontiers in Immunology 8:1882. doi: 10.3389/fimmu.2017.01882.
   PubMed Web of Science ®Google Scholar
• Lin, H. V., A. Frassetto, E. J. Kowalik, A. R. Nawrocki, M. M. Lu, J. R. Kosinski, J. A. Hubert, D. Szeto, X. Yao, G. Forrest, et al. 2012. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 7 (4):e35240. doi: 10.1371/journal.pone.0035240.
   PubMed Web of Science ®Google Scholar
• Liu, X., S. Cao, and X. Zhang. 2015. Modulation of gut microbiota-brain axis by probiotics, prebiotics, and diet. Journal of Agricultural and Food Chemistry 63 (36):7885–95. doi: 10.1021/acs.jafc.5b02404.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price, J., G. Abu-Ali, and C. Huttenhower. 2016. The healthy human microbiome. Genome Medicine 8 (1):51. doi: 10.1186/s13073-016-0307-y.
   PubMed Web of Science ®Google Scholar
• Lu, Y., C. Fan, P. Li, Y. Lu, X. Chang, and K. Qi. 2016. Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota. Scientific Reports 6:37589. doi: 10.1038/srep37589.
   PubMed Web of Science ®Google Scholar
• Mahowald, M. A., F. E. Rey, H. Seedorf, P. J. Turnbaugh, R. S. Fulton, A. Wollam, N. Shah, C. Wang, V. Magrini, R. K. Wilson, et al. 2009. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proceedings of the National Academy of Sciences of the United States of America 106 (14):5859–64. doi: 10.1073/pnas.0901529106.
   PubMed Web of Science ®Google Scholar
• Manach, C., G. Williamson, C. Morand, A. Scalbert, and C. Remesy. 2005. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition 81 (1 Suppl):230S–42S. doi: 10.1093/ajcn/81.1.230S.
   PubMed Web of Science ®Google Scholar
• Martin-Gallausiaux, C., L. Marinelli, H. M. Blottiere, P. Larraufie, and N. Lapaque. 2021. SCFA: Mechanisms and functional importance in the gut. The Proceedings of the Nutrition Society 80 (1):37–49. doi: 10.1017/S0029665120006916.
   PubMed Web of Science ®Google Scholar
• Martinez, K. B., J. F. Pierre, and E. B. Chang. 2016. The gut microbiota: The gateway to improved metabolism. Gastroenterology Clinics of North America 45 (4):601–14. doi: 10.1016/j.gtc.2016.07.001.
   PubMed Web of Science ®Google Scholar
• Mehrpouya-Bahrami, P., K. N. Chitrala, M. S. Ganewatta, C. Tang, E. A. Murphy, R. T. Enos, K. T. Velazquez, J. McCellan, M. Nagarkatti, and P. Nagarkatti. 2017. Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity. Scientific Reports 7 (1):15645. doi: 10.1038/s41598-017-15154-6.
   PubMedGoogle Scholar
• Milligan, G., L. A. Stoddart, and N. J. Smith. 2009. Agonism and allosterism: The pharmacology of the free fatty acid receptors FFA2 and FFA3. British Journal of Pharmacology 158 (1):146–53. doi: 10.1111/j.1476-5381.2009.00421.x.
   PubMed Web of Science ®Google Scholar
• Ozdal, T., D. A. Sela, J. Xiao, D. Boyacioglu, F. Chen, and E. Capanoglu. 2016. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients 8 (2):78. doi: 10.3390/nu8020078.
   PubMed Web of Science ®Google Scholar
• Patcharatrakul, T, and S. Gonlachanvit. 2016. Chili peppers, curcumins, and prebiotics in gastrointestinal health and disease. Current Gastroenterology Reports 18 (4):19. doi: 10.1007/s11894-016-0494-0.
   PubMedGoogle Scholar
• Perry, R. J., L. Peng, N. A. Barry, G. W. Cline, D. Zhang, R. L. Cardone, K. F. Petersen, R. G. Kibbey, A. L. Goodman, and G. I. Shulman. 2016. Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature 534 (7606):213–7. doi: 10.1038/nature18309.
   PubMed Web of Science ®Google Scholar
• Porras, D., E. Nistal, S. Martinez-Florez, S. Pisonero-Vaquero, J. L. Olcoz, R. Jover, J. Gonzalez-Gallego, M. V. Garcia-Mediavilla, and S. Sanchez-Campos. 2017. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology & Medicine 102:188–202. doi: 10.1016/j.freeradbiomed.2016.11.037.
   PubMed Web of Science ®Google Scholar
• Psichas, A., M. L. Sleeth, K. G. Murphy, L. Brooks, G. A. Bewick, A. C. Hanyaloglu, M. A. Ghatei, S. R. Bloom, and G. Frost. 2015. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. International Journal of Obesity 39 (3):424–9. doi: 10.1038/ijo.2014.153.
   PubMed Web of Science ®Google Scholar
• Qin, J., R. Li, J. Raes, M. Arumugam, K. S. Burgdorf, C. Manichanh, T. Nielsen, N. Pons, F. Levenez, T. Yamada, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (7285):59–65. doi: 10.1038/nature08821.
   PubMed Web of Science ®Google Scholar
• Rastelli, M., C. Knauf, and P. D. Cani. 2018. Gut microbes and health: A focus on the mechanisms linking microbes, obesity, and related disorders. Obesity 26 (5):792–800. doi: 10.1002/oby.22175.
   PubMed Web of Science ®Google Scholar
• Rook, G., F. Backhed, B. R. Levin, M. J. McFall-Ngai, and A. R. McLean. 2017. Evolution, human-microbe interactions, and life history plasticity. The Lancet 390 (10093):521–30. doi: 10.1016/S0140-6736(17)30566-4.
   PubMed Web of Science ®Google Scholar
• Rumberger, J. M., J. R. Arch, and A. Green. 2014. Butyrate and other short-chain fatty acids increase the rate of lipolysis in 3T3-L1 adipocytes. PeerJ 2:e611. doi: 10.7717/peerj.611.
   PubMed Web of Science ®Google Scholar
• Sanders, M. E., D. J. Merenstein, G. Reid, G. R. Gibson, and R. A. Rastall. 2019. Probiotics and prebiotics in intestinal health and disease: From biology to the clinic. Nature Reviews Gastroenterology & Hepatology 16 (10):605–16. doi: 10.1038/s41575-019-0173-3.
   PubMed Web of Science ®Google Scholar
• Santini, V., A. Gozzini, and G. Ferrari. 2007. Histone deacetylase inhibitors: Molecular and biological activity as a premise to clinical application. Current Drug Metabolism 8 (4):383–93. doi: 10.2174/138920007780655397.
   PubMed Web of Science ®Google Scholar
• Schwiertz, A., D. Taras, K. Schafer, S. Beijer, N. A. Bos, C. Donus, and P. D. Hardt. 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18 (1):190–5. doi: 10.1038/oby.2009.167.
   PubMed Web of Science ®Google Scholar
• Sender, R., S. Fuchs, and R. Milo. 2016. Revised estimates for the number of human and bacteria cells in the body. PLoS Biology 14 (8):e1002533. doi: 10.1371/journal.pbio.1002533.
   PubMed Web of Science ®Google Scholar
• Shahid, S. U., and U. Irfan. 2018. The gut microbiota and its potential role in obesity. Future Microbiology 13:589–603. doi: 10.2217/fmb-2017-0179.
   PubMed Web of Science ®Google Scholar
• Song, J. X., H. Ren, Y. F. Gao, C. Y. Lee, S. F. Li, F. Zhang, L. Li, and H. Chen. 2017. Dietary capsaicin improves glucose homeostasis and alters the gut microbiota in obese diabetic ob/ob mice. Frontiers in Physiology 8:602. doi: 10.3389/fphys.2017.00602.
   PubMed Web of Science ®Google Scholar
• Stinson, L. F., M. S. Payne, and J. A. Keelan. 2017. Planting the seed: Origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota. Critical Reviews in Microbiology 43 (3):352–69. doi: 10.1080/1040841X.2016.1211088.
   PubMed Web of Science ®Google Scholar
• Sung, M. M., T. T. Kim, E. Denou, C.-L M. Soltys, S. M. Hamza, N. J. Byrne, G. Masson, H. Park, D. S. Wishart, K. L. Madsen, et al. 2017. Improved glucose homeostasis in obese mice treated with resveratrol is associated with alterations in the gut microbiome. Diabetes 66 (2):418–25. doi: 10.2337/db16-0680.
   PubMed Web of Science ®Google Scholar
• Tamburini, S., N. Shen, H. C. Wu, and J. C. Clemente. 2016. The microbiome in early life: Implications for health outcomes. Nature Medicine 22 (7):713–22. doi: 10.1038/nm.4142.
   PubMed Web of Science ®Google Scholar
• Tan, J., C. McKenzie, M. Potamitis, A. N. Thorburn, C. R. Mackay, and L. Macia. 2014. The role of short-chain fatty acids in health and disease. Advances in Immunology 121:91–119. doi: 10.1016/B978-0-12-800100-4.00003-9.
   PubMed Web of Science ®Google Scholar
• Thangaraju, M., G. A. Cresci, K. Liu, S. Ananth, J. P. Gnanaprakasam, D. D. Browning, J. D. Mellinger, S. B. Smith, G. J. Digby, N. A. Lambert, et al. 2009. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Research 69 (7):2826–32. doi: 10.1158/0008-5472.CAN-08-4466.
   PubMed Web of Science ®Google Scholar
• Tolhurst, G., H. Heffron, Y. S. Lam, H. E. Parker, A. M. Habib, E. Diakogiannaki, J. Cameron, J. Grosse, F. Reimann, and F. M. Gribble. 2012. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61 (2):364–71. doi: 10.2337/db11-1019.
   PubMed Web of Science ®Google Scholar
• Tremblay, A., H. Arguin, and S. Panahi. 2016. Capsaicinoids: A spicy solution to the management of obesity? International Journal of Obesity (2005) 40 (8):1198–204. doi: 10.1038/ijo.2015.253.
   PubMed Web of Science ®Google Scholar
• Tsao, R. 2010. Chemistry and biochemistry of dietary polyphenols. Nutrients 2 (12):1231–46. doi: 10.3390/nu2121231.
   PubMed Web of Science ®Google Scholar
• Turnbaugh, P. J., R. E. Ley, M. Hamady, C. M. Fraser-Liggett, R. Knight, and J. I. Gordon. 2007. The human microbiome project. Nature 449 (7164):804–10. doi: 10.1038/nature06244.
   PubMed Web of Science ®Google Scholar
• Unno, T., T. Hisada, and S. Takahashi. 2015. Hesperetin modifies the composition of fecal microbiota and increases cecal levels of short-chain fatty acids in rats. Journal of Agricultural and Food Chemistry 63 (36):7952–7. doi: 10.1021/acs.jafc.5b02649.
   PubMed Web of Science ®Google Scholar
• Unno, T., M. Sakuma, and S. Mitsuhashi. 2014. Effect of dietary supplementation of (-)-epigallocatechin gallate on gut microbiota and biomarkers of colonic fermentation in rats. Journal of Nutritional Science and Vitaminology 60 (3):213–9. doi: 10.3177/jnsv.60.213.
   PubMed Web of Science ®Google Scholar
• van der Beek, C. M., E. E. Canfora, K. Lenaerts, F. J. Troost, S. Damink, J. J. Holst, A. A. M. Masclee, C. H. C. Dejong, and E. E. Blaak. 2016. Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. Clinical Science 130 (22):2073–82. doi: 10.1042/CS20160263.
   PubMed Web of Science ®Google Scholar
• Wang, H. X, and Y. P. Wang. 2016. Gut microbiota-brain axis. Chinese Medical Journal 129 (19):2373–80. doi: 10.4103/0366-6999.190667.
   PubMed Web of Science ®Google Scholar
• Wang, Y., C. Tang, Y. Tang, H. Yin, and X. Liu. 2020. Capsaicin has an anti-obesity effect through alterations in gut microbiota populations and short-chain fatty acid concentrations. Food & Nutrition Research 64. doi: 10.29219/fnr.v64.3525.
   Web of Science ®Google Scholar
• Williamson, G., and M. N. Clifford. 2017. Role of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols. Biochemical Pharmacology 139:24–39. doi: 10.1016/j.bcp.2017.03.012.
   PubMed Web of Science ®Google Scholar
• Wong, J. M., R. de Souza, C. W. Kendall, A. Emam, and D. J. Jenkins. 2006. Colonic health: Fermentation and short chain fatty acids. Journal of Clinical Gastroenterology 40 (3):235–43.
   PubMed Web of Science ®Google Scholar
• Yamashita, H., K. Fujisawa, E. Ito, S. Idei, N. Kawaguchi, M. Kimoto, M. Hiemori, and H. Tsuji. 2007. Improvement of obesity and glucose tolerance by acetate in Type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Bioscience, Biotechnology, and Biochemistry 71 (5):1236–43. doi: 10.1271/bbb.60668.
   PubMed Web of Science ®Google Scholar
• Yang, C., Q. Deng, J. Xu, X. Wang, C. Hu, H. Tang, and F. Huang. 2019. Sinapic acid and resveratrol alleviate oxidative stress with modulation of gut microbiota in high-fat diet-fed rats. Food Research International 116:1202–11. doi: 10.1016/j.foodres.2018.10.003.
   PubMed Web of Science ®Google Scholar
• Yatsunenko, T., F. E. Rey, M. J. Manary, I. Trehan, M. G. Dominguez-Bello, M. Contreras, M. Magris, G. Hidalgo, R. N. Baldassano, A. P. Anokhin, et al. 2012. Human gut microbiome viewed across age and geography. Nature 486 (7402):222–7. doi: 10.1038/nature11053.
   PubMed Web of Science ®Google Scholar
• Zhang, S., J. Zhao, F. Xie, H. He, L. J. Johnston, X. Dai, C. Wu, and X. Ma. 2021. Dietary fiber-derived short-chain fatty acids: A potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease. Obesity Reviews 22 (11):e13316. doi: 10.1111/obr.13316.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., P. Dua, and W. J. Lukiw. 2015. Microbial sources of amyloid and relevance to amyloidogenesis and Alzheimer’s disease (AD). Journal of Alzheimer’s Disease & Parkinsonism 5 (1):177. doi: 10.4172/2161-0460.1000177.
   PubMedGoogle Scholar